PMID: 6985426Jan 1, 1982Paper

Effect of rescue treatment with high doses of methotrexate (MTX) followed by leucovorin (LV) on neoplastic cells (HeLa line) and normal sensitized peripheral lymphocytes

Revista española de oncología
A RuanoY Valladares

Abstract

Employing the pharmacologic simulator under time lapse microcinematography described elsewhere, the authors study in this work the rescue treatment with high doses of methotrexate (MTX) followed by leucovorin rescue 6 and 24 hours after MTX addition. The experiments were done on mixed cultures of HeLa cells and HeLa cell-sensitized human lymphoblasts. MTX alone produces an extensive cell degeneration, that is never complete, 2300 micrograms/ml leucovorin have no toxic effect neither upon HeLa cells nor lymphoblasts. Higher amounts of leucovorin stimulate the growth of the neoplastic cells, but the lymphoblasts are not affected. Leucovorin added 6 or 24 hours after MTX inhibits the mitotic activity completely for 54 to 62 hours. Neoplastic cells death rate is never higher than 20 per 100. Lymphoblasts die much earlier reaching 50 per 100 after 50-58 hours. Cell degeneration is accompanied by large morphological and morphodynamic modifications. Rescue treatment in vitro, under condition simulating in vivo kinetics of the drugs is not able to eliminate the cancer cells. Actually, leucovorin stimulates the growth of the neoplastic cells and rescues great part of them out from the G0 state into the active cell cycle when leucovorin ...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.